Cizzle Bio will attend the AACR Annual Meeting 2026 in San Diego from April 17 to 22. The meeting brings together global leaders in cancer research, translational science, and clinical innovation.

Cizzle Bio will attend Capital Factory House @ SXSW 2026 in Austin from March 12 to 16. The event connects entrepreneurs, investors, and innovators during SXSW for networking and collaboration.

Cizzle Bio will attend the GO2 For Lung Cancer Voices Summit from March 1 to 3, 2026 in Washington, DC. The summit unites the lung cancer community for education, advocacy training, and engagement with federal policymakers.

Cizzle Bio will attend the 23rd Annual Winter Lung Cancer Conference from January 23 to 25, 2026 in Miami Beach. The conference brings together oncology experts to discuss advances in lung cancer diagnostics, biomarkers, and clinical management.

Cizzle Bio will attend the ASCO Gastrointestinal Cancers Symposium on January 8 to 10, 2026 in San Francisco. This premier event brings together global oncology leaders to discuss new research, diagnostic advances, and solution-focused strategies in GI cancers.

Cizzle Bio will attend the San Antonio Breast Cancer Symposium on December 9 to 12, 2025 in San Antonio, Texas. This premier global meeting covers the latest advances in breast cancer biology, diagnostics, biomarkers, clinical trials, and translational research.

Cizzle Bio will attend the 67th ASH Annual Meeting and Exposition on December 6 to 9, 2025 in Orlando. This premier hematology event features cutting edge research, clinical updates, and new developments in diagnostics, biomarkers, and translational science.

Cizzle Bio is proud to support the 4th Stomach Cancer Patient Empowerment Summit, taking place November 14–16, 2025, in Long Beach, CA. Hosted by StoCAN, this free three-day event unites patients, caregivers, and healthcare professionals under the theme “Patient-Powered Progress” — fostering collaboration, education, and hope in the fight against stomach cancer.

Cizzle Bio will attend the 15th Annual AVBCC Summit in New York City from October 22–24, 2025. Our CEO, Bill Behnke, will moderate a panel on advancing cancer diagnostics to commercialization.

Cizzle Bio will attend CHEST 2025 in Chicago, October 19–22. This premier meeting of pulmonary and critical care experts marks 90 years of advancing chest medicine. Our attendance reflects our commitment to early detection and supporting clinicians in the fight against lung cancer.

Cizzle Bio is attending the 17th Annual Next Generation Dx Summit from August 18–20, 2025, in Washington, D.C. We look forward to engaging with global leaders in diagnostics and sharing insights on early detection through biomarker-based innovation.

Cizzle Bio is attending the 8th Annual AABIP Conference in Austin, TX on August 14–16, 2025. We’ll be connecting with leaders in interventional pulmonology to discuss our biomarker blood tests, CIZ1B for lung cancer and DEX-G2 for gastric cancer.

Cizzle Bio will attend the 2025 BIO International Convention in Boston, June 16–19. Meet with our team to learn how our biomarker blood tests are transforming early cancer detection.

Cizzle Bio is proud to announce our attendance at the 2025 ASCO Annual Meeting, taking place from May 30 to June 3, 2025, at McCormick Place, Chicago. This premier oncology event offers a global platform to explore innovations, engage with researchers, and advance our mission of early cancer detection.

Cizzle Bio is excited to attend the AACR Annual Meeting 2025, taking place from April 25-30 at McCormick Place, Chicago. This leading event brings together the brightest minds in cancer research and diagnostics. Learn more about why we’re attending.